NCT04556838View on ClinicalTrials.gov

Study of VVN001 Ophthalmic Solution in Dry Eye Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

December 3, 2020

Primary Completion Date

December 1, 2021

Study Completion Date

December 1, 2021

Conditions
Dry Eye
Interventions
DRUG

VVN001 Ophthalmic Solution 1%

VVN001 Ophthalmic Solution 1%

DRUG

VVN001 Ophthalmic Solution 5%

VVN001 Ophthalmic Solution 5%

DRUG

Vehicle

VVN001 Ophthalmic Solution Vehicle

Trial Locations (1)

27703

Lexitas, Durham

All Listed Sponsors
lead

VivaVision Biotech, Inc

INDUSTRY

NCT04556838 - Study of VVN001 Ophthalmic Solution in Dry Eye Disease | Biotech Hunter | Biotech Hunter